Want to track IMNM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immunome, Inc. (IMNM) Statistics
Valuation metrics
Market Cap 1.94B
Enterprise value 1.91B
Trailing P/E (ttm) -7.08
Forward P/E -
PEG ratio -0.42
Price/Sales (ttm) 595.95
Price/Book (mrq) 3.88
Enterprise Value/Revenue 451.74
Enterprise Value/EBITDA -7.61
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.49M
Average volume (90 days) 1.27M
Price summary
52-Week low 14.64
52-Week high 30.06
Beta -
50-Day moving average 21.43
200-Day moving average 22.62
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -55.94%
Operating margin -59.48%
Operational effectiveness
Return on assets -0.45%
Return on equity -0.51%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.25
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.59
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 15.08%
Book value per share (mrq) 4.64
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
